Anzeige
Meldung des Tages: Mit Graphen gegen jede Abwehr — Die Zukunft der Drohnen ist da

Bausch Health News

Aktie
WKN:  A2JQ1X ISIN:  CA0717341071 US-Symbol:  BHC Branche:  Pharmazeutika Land:  Kanada
Keine aktuellen Kursdaten verfügbar
Depot/Watchlist
Marktkapitalisierung *
2,26 Mrd. €
Streubesitz
22,33%
KGV
-67,17
Index-Zuordnung
-
Weiter aufwärts? Long handeln - Jetzt mit Hebel 5,88: MK8DC5
Werbung

Bausch Health News

29.04.26 - PR Newswire
BAUSCH HEALTH ANNOUNCES FIRST QUARTER 2026 RESULTS
BAUSCH HEALTH ANNOUNCES FIRST QUARTER 2026 RESULTS PR Newswire
14.04.26 - PR Newswire
Bausch Health's Dermatology Business, Ortho Dermatologics, Announces the Launch of Biafine®, an Iconic French Skincare Product, Through Convenient Online Ordering
Bausch Health's Dermatology Business, Ortho Dermatologics, Announces the Launch of Biafine®, an Iconic French Skincare Product, Through Convenient Online Ordering PR ...
31.03.26 - PR Newswire
Bausch Health to Announce First Quarter 2026 Results on April 29, 2026
Bausch Health to Announce First Quarter 2026 Results on April 29, 2026 PR Newswire
26.03.26 - PR Newswire
Bausch Health Announces Ortho Dermatologics 2026 ASPIRE HIGHER Scholarship Program
Bausch Health Announces Ortho Dermatologics 2026 ASPIRE HIGHER Scholarship Program PR Newswire
23.02.26 - PR Newswire
Bausch Health's Aesthetics Business, Solta Medical, Announces the Launch of Clear + Brilliant® Touch Laser in Canada
Bausch Health's Aesthetics Business, Solta Medical, Announces the Launch of Clear + Brilliant® Touch Laser in Canada PR Newswire
19.02.26 - PR Newswire
Bausch Health's OraPharma Celebrates 25 Years of ARESTIN® (minocycline HCl) Microspheres
Bausch Health's OraPharma Celebrates 25 Years of ARESTIN® (minocycline HCl) Microspheres PR Newswire
18.02.26 - PR Newswire
BAUSCH HEALTH ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2025 RESULTS
BAUSCH HEALTH ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2025 RESULTS PR Newswire
17.02.26 - PR Newswire
Bausch Health to Participate in the J.P. Morgan Global Leveraged Finance Conference
Bausch Health to Participate in the J.P. Morgan Global Leveraged Finance Conference PR Newswire
11.02.26 - PR Newswire
Bausch Health Announces 2026 Gastrointestinal Health Scholars Program
Bausch Health Announces 2026 Gastrointestinal Health Scholars Program PR Newswire
23.01.26 - PR Newswire
Bausch Health Provides Update on RED-C Phase 3 Clinical Trials
Bausch Health Provides Update on RED-C Phase 3 Clinical Trials PR Newswire
21.01.26 - PR Newswire
Bausch Health to Announce Fourth Quarter and Full Year 2025 Results on February 18, 2026
Bausch Health to Announce Fourth Quarter and Full Year 2025 Results on February 18, 2026 PR Newswire
05.01.26 - PR Newswire
Bausch Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference
Bausch Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference PR Newswire
11.09.25 - PR Newswire
Bausch Health Completes Acquisition of DURECT Corporation, Expanding Late-stage Liver Disease Portfolio
Bausch Health Completes Acquisition of DURECT Corporation, Expanding Late-​stage Liver Disease Portfolio PR Newswire
29.07.25 - PR Newswire
Bausch Health to Acquire DURECT Corporation, Strengthening Commitment to Developing Innovative Solutions for Patients with Liver Disease
Bausch Health to Acquire DURECT Corporation, Strengthening Commitment to Developing Innovative Solutions for Patients with Liver Disease PR Newswire

Newssuche

Videos

newspaper
26.04.26
Big Fish Strategy Einführung
Strategie-​Paket inklusive Live-​Webinar am 3.5., Videoaufzeichnung, Unterlagen und Nachbetreuung JETZT ... Mehr »
Anzeige

Aktie im Fokus

Mit Graphen gegen jede Abwehr
Plaid Technologies
0,396 €
+7,03%
Plaid Technologies Chart
Die Zukunft der Drohnen ist da
Mehr zur Aktie »